Vivus Delays Annual Meeting, Blasts Activist Investor

Law360, New York (July 15, 2013, 5:41 PM EDT) -- Vivus Inc. on Sunday postponed its buzzed-about annual meeting that is set to resolve a fiery fight for control between the drugmaker and its largest shareholder, apparently putting an end to negotiations aimed at reaching a settlement between the two.

In pushing the shareholder summit back three days to Thursday, Vivus, known for its obesity treatments, told investors that First Manhattan Co. made misleading comments in the thick of the proxy fight and asked the U.S. Securities and Exchange Commission to mandate “corrective actions.”

But First...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.